跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ketesse - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ketesse
Approved
STANDARD
Ketesse
A.Menarini Manufacturing Logistics and Services S.r.l.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ee3eff737034402d
Company
A.Menarini Manufacturing Logistics and Services S.r.l.
Type
Standard
Approval Details
Approval Id
ee3eff737034402d
Drug Approval Philippines Name
Ketesse
Product Name
Ketesse
Registration Number
DR-XY36266
Brand Name
Ketesse
Generic Name
Dexketoprofen (as trometamol)
Dosage Form
Solution for Injection or Concentrate for Solution for Infusion (I.M./I.V.)
Dosage Strength
25 mg/mL (50 mg/2mL)
Manufacturer
A.Menarini Manufacturing Logistics and Services S.r.l.
Trader
A.Menarini Asia – Pacific Holdings Pte. Ltd.
Importer
A.Menarini Philippines Inc.
Distributor
A.Menarini Philippines Inc.
Issuance Date
28 May 2024
Expiry Date
17 July 2029
Pharmacologic Category
Anti-Inflammatory and Anti-Rheumatic Product Non-Steroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ee3eff737034402d
Type
Standard
Back to Philippines FDA Approvals